| abstract |
The present invention provides methods and therapeutics for limiting development of neurodegeneration in subjects at risk, e.g. diabetic patients and subjects with metabolic syndrome. The prophylactic/ therapeutic method of the invention involves the administration of an angiotensin analogue, e.g. the fragment Ang II (1-7). |